Breast and lung metastasis from pancreatic neuroendocrine carcinoma

Author(s): Shevonne Satahoo-Dawes | Joshua Palmer | Eddie W Manning III | Joe Levi

A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy

Author(s): Tristan D Yan | Christopher Qian Cao | Stine Munkholm-Larsen

Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon

Author(s): Tomofumi Miura, Nobuaki Suzuki, Junichiro Nakamura, Satoshi Yamada, Tsutomu Miura, Masahiko Yanagi, Hiroyuki Usuda, Iwao Emura, Toru Takahashi

Coronary Vasospasm Secondary to 5-Fluorouracil and Its Management: Case Report

Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX

Author(s): Xue-Feng Ni, Chang-Ping Wu, Jing-Ting Jiang

Surgery for rare aneurysm associated with colorectal cancer

Author(s): Pei-Hua Lu, Guo-Qing Tao, Wei Shen, Bin Cai, Zhi-Yang Jiang, Jian Sun

Pneumatosis cystoides intestinalis after fluorouracil chemotherapy for rectal cancer

Author(s): Kenji Mimatsu, Takatsugu Oida, Atsushi Kawasaki, Hisao Kano, Youichi Kuboi, Osamu Aramaki, Sadao Amano

Primary signet ring cell carcinoma of the appendix: A rare case report and our 18-year experience

Author(s): Yoon Ho Ko, Chan-Kwon Jung, Soon Nam Oh, Tae Hee Kim, Hye Sung Won, Jin Hyoung Kang, Hyung Jin Kim, Won Kyung Kang, Seong Taek Oh, Young Seon Hong

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer

Endoscopic Resection and Topical 5-Fluorouracil as an Alternative Treatment to Craniofacial Resection for the Management of Primary Intestinal-Type Sinonasal Adenocarcinoma

Author(s): Simon Mackie | Tass Malik | Hisham Khalil

Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer

Author(s): Roberto Biffi, Nicola Fazio, Fabrizio Luca, Antonio Chiappa, Bruno Andreoni, Maria Giulia Zampino, Arnaud Roth, Jan Christian Schuller, Giancarla Fiori, Franco Orsi, Guido Bonomo, Cristiano Crosta, Olivier Huber

Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma

Author(s): Jongkonnee Thanasai, Temduang Limpaiboon, Patcharee Jearanaikoon, Banchob Sripa, Chawalit Pairojkul, Srisurang Tantimavanich, Masanao Miwa

Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites

Author(s): Ming-Chen Ba, Shu-Zhong Cui, Sheng-Qu Lin, Yun-Qiang Tang, Yin-Bing Wu, Bin Wang, Xiang-Liang Zhang

Overall Survival rate in Breast Cancer patients treated with 5-Fluorouracil: a Review of Randomized Clinical Trials

Author(s): Uday Chandra Kumar, | Devarayalu BVSK | Mahmood Shaik

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China

Author(s): Xin-Zu Chen, Kun Jiang, Jian-Kun Hu, Bo Zhang, Hong-Feng Gou, Kun Yang, Zhi-Xin Chen, Jia-Ping Chen

Oral Administration of Ren-Shen-Yang-Rong-Tang ‘Ninjin’yoeito’ Protects against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-Induced Anemia

Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report

Author(s): Benghiat Helen | Al-Niaimi Amjad

Comparative study of the toxicity of 5-fluorouracil-adriamycin-cyclophosphamide versus adriamycin-cyclophosphamide followed by paclitaxel in carcinoma breast

Author(s): Palappallil Dhanya | Nair Bindu | Jayakumar K | Puvathalil Ramani

Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: Data from a tertiary cancer center in northern India

Standard guidelines of care: Keloids and hypertrophic scars

Author(s): Gupta Somesh | Sharma V

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

Author(s): Sánchez-Aragó María | Cuezva José

Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study

Author(s): Chintamani | Tandon Megha | Mishra Ashwani | Agarwal Usha | Saxena Sunita

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer

Concurrent breast stroma sarcoma and breast carcinoma: a case report

Minute liver metastases from a rectal carcinoid: A case report and review

Capecitabine for locally advanced and metastatic colorectal cancer: A review

Author(s): Georgios V Koukourakis | Georgios Zacharias | John Tsalafoutas | Dimitrios Theodoridis | Vassilios Kouloulias

Current status of therapy for breast cancer worldwide and in Japan

Author(s): Youngjin Park | Tomoaki Kitahara | Ryuichi Takagi | Ryoji Kato

Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer

Author(s): Paul H Sugarbaker | Kurt Van der Speeten | O Anthony Stuart

Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance

Author(s): Samuel Wolf, Jana Lorenz, Joachim Mössner, Marcus Wiedmann

Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

Author(s): Soley Bayraktar, Ulas Darda Bayraktar, Caio Max Rocha-Lima

Surgically treated primary malignant tumor of small bowel: A clinical analysis

Author(s): Shao-Liang Han, Jun Cheng, Hong-Zhong Zhou, Sheng-Cong Guo, Zeng-Rong Jia, Peng-Fei Wang

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer

Author(s): Xiao-Dong Li, Hua Shen, Jing-Ting Jiang, Han-Ze Zhang, Xiao Zheng, Yong-Qian Shu, Chang-Ping Wu

Establishment of a human hepatoma multidrug resistant cell line in vitro

Author(s): Yuan Zhou, Xian-Long Ling, Shi-Wei Li, Xin-Qiang Li, Bin Yan

Capecitabine with radiation is an effective adjuvant therapy in gastric cancers

Author(s): Chee Kian Tham, Su Pin Choo, Donald Yew Hee Poon, Han Chong Toh, Simon Yew Kuang Ong, Sze Huey Tan, Michael Lian Chek Wang, Kian Fong Foo

Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study

Author(s): Julien Edeline, Jean-Luc Raoul, Elodie Vauleon, Anne Guillygomac’h, Karim Boudjema, Eveline Boucher

Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer

Author(s): Wen-Hua Li, Jun-Jie Peng, Jia-Qing Xiang, Wei Chen, San-Jun Cai, Wen Zhang

Mature Results of a Prospective Randomized Trial Comparing 5-Flourouracil with Leucovorin to 5-Flourouracil with Levamisole as Adjuvant Therapy of Stage II and III Colorectal Cancer- The Israel Cooperative Oncology Group (ICOG) Study

Author(s): Arie Figer, Aviram Nissan, Adi Shani, Riva Borovick, Mariana Stiener, Mario Baras, Herbert R. Freund, Aaron Sulkes, Alexander Stojadinovic, Tamar Peretz

Decreasing Dosage of Irinotecan, 5-Flurouracil (5-FU) and Leucovorin (LV) in the Treatment of Advanced and /or Metastatic Colorectal Cancer: A Phase II Study

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

Author(s): Janja Ocvirk, Thomas Brodowicz, Fritz Wrba, Tudor E Ciuleanu, Galina Kurteva, Semir Beslija, Ivan Koza, Zsuzsanna Pápai, Diethelm Messinger, Ugur Yilmaz, Zsolt Faluhelyi, Suayib Yalcin, Demetris Papamichael, Miklós Wenczl, Zrinka Mrsic-Krmpotic, Einat Shacham-Shmueli, Damir Vrbanec, Regina Esser, Werner Scheithauer, Christoph C Zielinski

Capecitabine in the management of colorectal cancer

Author(s): Hirsch BR | Zafar SY

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies

Author(s): Bruno Christian Koehler, Toni Urbanik, Binje Vick, Regina Johanna Boger, Steffen Heeger, Peter R Galle, Marcus Schuchmann, Henning Schulze-Bergkamen

Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma

Author(s): You-Hua Wu, Jian-Guo Cao, Hong-Lin Xiang, Hong Xia, Yong Qin, A-Ji Huang, Di Xiao, Fang Xu

Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis

Author(s): Xiao-Li Chen, Sang-Zhu Ciren, Hui Zhang, Li-Geng Duan, Alexander J Wesley

Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin

Author(s): Xiang-Wen Tan, Hong Xia, Jin-Hua Xu, Jian-Guo Cao

Ki-67 biomarker in breast cancer of Indian women

Author(s): Amit V. Patil | Rajeev Singhai | Rahul S. Bhamre | Vinayak W. Patil

Gli-1 siRNA induced apoptosis in Huh7 cells

Author(s): Xi-Lin Chen, Liang-Qi Cao, Miao-Rong She, Qian Wang, Xiao-Hui Huang, Xin-Hui Fu

Effects of Wei Chang An on expression of multiple genes in human gastric cancer grafted onto nude mice

Author(s): Ai-Guang Zhao, Ting Li, Sheng-Fu You, Hai-Lei Zhao, Ying Gu, Lai-Di Tang, Jin-Kun Yang

Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy

Author(s): Christiane Jakob, Torsten Liersch, Wolfdietrich Meyer, Heinz Becker, Gustavo B Baretton, Daniela E Aust

Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States

Author(s): Muhammad Wasif Saif, Nianwen Shi, Susan Zelt

Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study

Author(s): Francois Ghiringhelli, Boris Guiu, Bruno Chauffert, Sylvain Ladoire

Effect of early preoperative 5-fluorouracil on the integrity of colonic anastomoses in rats

Author(s): Leyla Ozel, M Sefa Ozel, Ahmet Burak Toros, Melih Kara, Kemal Sırrı Ozkan, Gurkan Tellioglu, Osman Krand, Meral Koyuturk, Ibrahim Berber

Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats

Author(s): Zhi-Gang Wei, Guo-Xin Li, Xiang-Cheng Huang, Li Zhen, Jiang Yu, Hai-Jun Deng, Shan-Hua Qing, Ce Zhang

Myelophil, a mixture of Astragali Radix and Salviae Radix extract, moderates toxic side effects of fluorouracil in mice

Author(s): Jang Woo Shin, Myong Min Lee, Jin Young Son, Nam Heon Lee, Chong Kwan Cho, Won Kyu Chung, Jung Hyo Cho, Chang Gue Son

Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer

Author(s): Muhammad Wasif Saif

Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases

Author(s): Kiminori Uka, Hiroshi Aikata, Shintaro Takaki, Tomokazu Kawaoka, Hiromi Saneto, Daiki Miki, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama

Irinotecan therapy and molecular targets in colorectal cancer: A systemic review

Author(s): Jessica Weekes, Alfred King-Yin Lam, Sabe Sebesan, Yik-Hong Ho

Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice

Author(s): Dan-Ying Zhang, Xi-Zhong Shen, Ji-Yao Wang, Ling Dong, Yong-Li Zheng, Li-Li Wu

Bcl-x and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells

Author(s): Henning Schulze-Bergkamen, Roland Ehrenberg, Lothar Hickmann, Binje Vick, Toni Urbanik, Christoph C Schimanski, Martin R Berger, Arno Schad, Achim Weber, Steffen Heeger, Peter R Galle, Markus Moehler

Concurrent Chemoradiotherapy for Unresectable Thymic Carcinoma.

Author(s): Yen-Yang Chen | Cheng-Hua Huang | Yeh Tang | Hock-Lien Eng

Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluorouracil in colon cancer cell-bearing mice

Author(s): Simona Perboni, Cyril Bowers, Shinya Kojima, Akihiro Asakawa, Akio Inui

Bcl-2 expression significantly correlates with thymidylate synthase expression in colorectal cancer patients

Author(s): Riyad Bendardaf, Raija Ristämaki, Kari Syrjänen, Seppo Pyrhönen

Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells

Author(s): Mohamed Salah I Abaza, Abdul-Majeed A Bahman, Rajaa J Al-Attiyah

Interleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer

Author(s): Youngmin Choi, Mee-Sook Roh, Young-Seoub Hong, Hyung-Sik Lee, Won-Joo Hur

Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial

Author(s): Mostafaei A

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Mitomycin C (MMC) with Weekly 24-Hour Infusions of High-Dose 5-Fluorouracil and Leucovorin in Patients with Advanced Gastric Cancer

Author(s): Jen-Shi Chen | Yung-Chang Lin | Chi-Ting Liau | Cheng-Hsu Wang | Chung-Chi Liaw

Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases

Pedunculated gastric tube interposition in an esophageal cancer patient with prepyloric adenocarcinoma

Needling Revision with Subconjunctival 5-Fluorouracil in Failing Filtering Blebs

Author(s): Shirley Hsueh-Li Chang | Chiun-Ho Hou

Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin

Author(s): Yu Liu | Bao-An Liu

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

Author(s): Kaori Kadoyama, Ikuya Miki, Takao Tamura, JB Brown, Toshiyuki Sakaeda, Yasushi Okuno

Reproducibility and dose dependency of the antitumoral pharmacodynamic effect of some autochthonous polysaccharidic or polyphenolic biopreparations of fungal and vegetal origin

The in vivo assessment of the preclinical oncochemotherapeutic effectivness of some furostanolic glycosides

Concurrent Hypofractionated Radiotherapy and 5-Fluorouracil for Advanced Sarcomas of the Bone

Aktinik şelitis tedavisinde 5-fluorourasıl (5-fu) kullanımı: derleme ve iki olgunun sunumu

Author(s): Candan Efeoglu | Huseyin Koca | Taha Unal

HEPATIC ARTERIAL INFUSION AND INTRAVENOUS CHEMOTHERAPY IN UNRESECTABLE LIVER METASTASES FROM COLORECTAL CANCER VERSUS SYSTEMIC CHEMOTHERAPY ALONE

Author(s): C.Popa | S. Simion | B. Popa | T. Potecă | Sânziana Ionescu

Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells

IMMUNOTHERAPY WITH VISCUM ALBUM EXTRACT IN THE TREATMENT OF ADVANCED COLORECTAL CANCER

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

Predicting drug-target interaction in cancers using homology modeled structures of MTHFR gene

Author(s): KK. Ch

DESIGN AND DEVELOPMENT OF 5 - FLUOROURACIL LOADED BIODEGRADABLE MICROSPHERES

Author(s): Sheth Zankhana | Mudgal Shikha | Singh Mahendra | Gupta Mukesh

9Th International Congress of Medical Oncology & Hematology of Iran; 26-28 Nov., 2009 Olympic Hotel Tehran-Iran

Author(s): A A

Regulation of colon cancer recurrence and development of therapeutic strategies

Author(s): Shailender Singh Kanwar | Anuradha Poolla | Adhip PN Majumdar

Molecular interactions between anticancer drugs and iodinated contrast media: An in vitro spectroscopic study

Measurements of 5-FU Plasma Concentrations in Patients with Gastrointestinal Cancer: 5-FU Levels Reflect the 5-FU Dose Applied

Measurements of 5-FU Plasma Concentrations in Patients with Gastrointestinal Cancer: 5-FU Levels Reflect the 5-FU Dose Applied

9th International Congress of Medical Oncology & Hematology of Iran; 26-28 Nov., 2009 Olympic Hotel Tehran-Iran

Author(s): A A

The role of S-1 in the treatment of gastric cancer

Author(s): Blum MA | Suzuki A | Taketa T | Ajani J

Clinical Analysis of Bevacizumab Plus FOLFIRI Regimen as Front-Line Therapy for Chinese Patients with Advanced Colorectal Cancer

Par-4 Sensitizes Human Colon Cancer Cells to Chemoradiotherapy

Author(s): Daniel Contract | Heath Mackley | Rosalyn Bryson Irby

Randomized Trial Comparing Cyclophosphamide, Methotrexate, and 5-Fluorouracil (CMF) Regimen with Rotational CMFEV Regimen (E=Epirubicin, V=Vincristine) as Adjuvant Chemotherapy in Moderate Risk Operable Breast Carcinoma

Anticarcinogenic Activity of Leptadenia reticulata against Dalton’s Ascitic Lymphoma

Author(s): L. Sathiyanarayanan | Sinnathambi Arulmozhi | N. Chidambaranathan

Significance of differential expression of thymidylate synthase in normal and primary tumor tissues from patients with colorectal cancer

Obstructive jaundice secondary to pancreatic head adenocarcinoma in a young teenage boy: a case report

Author(s): Brahmi Sami | Khattab Mohammed | Mesbahi Omar

Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Variant angina pectoris associated with FOLFOX4 therapy

Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies

Author(s): Kobayakawa M | Kojima Y

Long term results of 5-Fluorouracil in glaucoma operation

Author(s): Hashemian M | Yazdani Sh

Life expectancy with perioperative chemotherapy and chemoradiotherapy for locally advanced gastric adenocarcinoma

Influence of different sugar cryoprotectants on the stability and physico-chemical characteristics of freeze-dried 5-fluorouracil plurilamellar vesicles

Author(s): Mohamed Mahmoud Nounou | Labiba El-Khordagui | Nawal Khalafallah | Said Khalil

"Long term results of intraoperative 5-FU in Glaucoma filtering procedures "

Author(s): "Hashemian MN | Yazdani S "

Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice

Comparison between daily and alternate-day use of topical 5-fluorouracil in treatment of actinic keratosis: Randomized controlled clinical trial

Author(s): Amir Houshang Ehsani | Mostafa Mirshams Shahshahani | Zahra Hallaji | Pedram Noormohammadpour

Effects of Combined Intralesional 5-Fluorouracil and Topical Silicone in Prevention of Keloids: A Double Blind Randomized Clinical Trial Study

Author(s): Ebrahim Hatamipour | Saadat Mehrabi | Mohsen Hatamipour | Hamid Reza Ghafarian Shirazi

Das kolorektale Karzinom - Möglichkeiten der palliativen Chemotherapie

Author(s): Stöger H

Palliative Chemotherapie und neue Therapieansätze beim kolorektalen Karzinom

Author(s): Scheithauer W

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Author(s): Brunner Thomas | Sauer Rolf | Fietkau Rainer

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

Author(s): Nautiyal Jyoti | Kanwar Shailender | Yu Yingjie | Majumdar Adhip

A reduction in the interstitial fluid pressure per se, does not enhance the uptake of the small molecule weight compound 5-fluorouracil into 4T1 mammary tumours

Author(s): Charlotte Jevne | Ingrid Moen | Gerd Salvesen | Rolf Kåre Reed | Linda Elin Birkhaug Stuhr

Metronomic Chemotherapy was Originally Designed and first used in 1994 for Early Stage Cancer - why is it Taking so Long to Proceed?

Author(s): Michael Retsky

Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA

Author(s): Lekha Nair K | Jagadeeshan S | Nair SA | Kumar GSV

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer

Author(s): Takao Tamura, Akiko Kuwahara, Kaori Kadoyama, Motohiro Yamamori, Kohshi Nishiguchi, Tsubasa Inokuma, Yoshiji Takemoto, Naoko Chayahara, Tatsuya Okuno, Ikuya Miki, Yoshimi Fujishima, Toshiyuki Sakaeda

Use of capecitabine in management of early colon cancer

Author(s): Hameed H | Cassidy J

Characterization of Crosslinked Poly (2-Hydroxyethyl Methacrylate-co-N-Vinyl-2-Pyrrolidone) as a Carrier for Controlled Drug Delivery

Author(s): *Subramanian Kaliappa Gounder and Vijayakumar Vediappan

A rare case of zolendronate infusion complication leading to glaucoma filtration surgery

Author(s): Khan A | Lascaratos G | Rane-Malcolm T | Sanders R

Evaluation of Anticancer Activity of Lagenaria siceraria Aerial Parts

Author(s): P. Saha | S. Kundu Sen | A. Bala | U.K. Mazumder | P.K. Haldar

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma

Author(s): Yan Dong | Dai Hong | Liu Jin-Wei

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression